STOCK TITAN

CONMED Corporation to Present at the J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
CONMED Corporation (CNMD) to Present at J.P. Morgan Healthcare Conference
Positive
  • None.
Negative
  • None.

LARGO, Fla.--(BUSINESS WIRE)-- CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the J.P. Morgan Healthcare Conference at 2:15 p.m. PT (5:15 p.m. ET) on Monday, January 8, 2024 in San Francisco, CA.

A live audio webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.conmed.com and will be available for replay following the event.

About CONMED Corporation

CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Company’s products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. For more information, visit www.conmed.com.

Forward-Looking Statements

This press release and associated presentation may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not limited to the risk factors discussed in the Company's Annual Report on Form 10-K for the full year ended December 31, 2022, listed under the heading Forward-Looking Statements in the Company’s most recently filed Form 10-Q and other risks and uncertainties, which may be detailed from time to time in reports filed by CONMED with the SEC. Any and all forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs, or projections as expressed in the forward-looking statements will actually occur or prove to be correct.

CONMED Corporation

Todd W. Garner

Chief Financial Officer

727-214-2975

ToddGarner@conmed.com

Source: CONMED Corporation

FAQ

What event is CONMED Corporation (CNMD) presenting at?

CONMED Corporation (CNMD) will present at the J.P. Morgan Healthcare Conference in San Francisco, CA.

Who will be presenting at the J.P. Morgan Healthcare Conference for CONMED Corporation (CNMD)?

Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will be presenting for CONMED Corporation (CNMD).

Where can I access the live audio webcast of the presentation for CONMED Corporation (CNMD)?

The live audio webcast of the presentation will be accessible through the 'Investors' section of CONMED Corporation's website at www.conmed.com.

When will the presentation at the J.P. Morgan Healthcare Conference for CONMED Corporation (CNMD) be available for replay?

The presentation will be available for replay following the event.

CONMED Corporation

NYSE:CNMD

CNMD Rankings

CNMD Latest News

CNMD Stock Data

2.17B
30.70M
0.58%
114.64%
7.66%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
LARGO